Predicting Drug-Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling. (2019)

First Author: Rajoli RKR
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/infdis/jiy726

PubMed Identifier: 30566691

Publication URI: http://europepmc.org/abstract/MED/30566691

Type: Journal Article/Review

Volume: 219

Parent Publication: The Journal of infectious diseases

Issue: 11

ISSN: 0022-1899